Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-10-25
DOI
https://doi.org/10.1016/j.ejca.2025.116051
Citations
2
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial

Ester Siemerink, Hedwig M. Blommestein, Danny Houtsma, Vincent van der Noort et al.
2 citations
European Journal of Cancer
Advanced Breast Cancer Therapies
3.04
article

Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial

Ester Siemerink, Hedwig M. Blommestein, Danny Houtsma, Vincent van der Noort, Annemieke van der Padt‐Pruijsten, Gabe S. Sonke, A. Elise van Leeuwen‐Stok, F. Van den Berkmortel, Hendrika M. Oosterkamp, Helga Droogendijk, Agnes Jager, Annette A. van Zweeden, Marlies L. van Bekkum, E. van den Pol, Cristina Guerrero Páez, Annemiek van Ommen‐Nijhof, Noor Wortelboer, Inge R. Konings, Jolien Tol, Seamus Kent
article en
2 citations

Abstract

No abstract available for this paper.
European Journal of CancerVol. 231
Dutch Cancer Society (NL), Amsterdam UMC Location University of Amsterdam (NL), The Netherlands Cancer Institute (NL), Medisch Centrum Haaglanden (NL), Borstkankervereniging Nederland (NL), Maasstad Ziekenhuis (NL), Zuyderland Medisch Centrum (NL), Netherlands Comprehensive Cancer Organisation (NL), Haga Hospital (NL), Ziekenhuis Amstelland (NL), Ziekenhuis Groep Twente (NL), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), Jeroen Bosch Ziekenhuis (NL), Bravis Ziekenhuis (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL), Delft University of Technology (NL)
ZonMw
Openalex Percentile: Top 7%
Advanced Breast Cancer Therapies
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.